BioCentury
ARTICLE | Company News

Diamyd, J&J deal

June 6, 2011 7:00 AM UTC

Johnson & Johnson's Ortho-McNeil-Janssen Pharmaceuticals Inc. subsidiary terminated a 2010 deal with Diamyd and returned rights to diabetes candidate Diamyd. In May, the product missed the primary end...